Sherman Mark Andrew's Form 4 filing
Dolby Laboratories, Inc.DLB · filed Feb 3, 2025
- Accession no.
- 0000950170-25-012643
- Filed
- Feb 3, 2025
- Trade date
- Jan 30, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.40M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Mark AndrewCIK 0001256708 | Officer (EVP, Gen. Counsel & Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Class A Common Stock | MOption exerciseAcquired | +40,000 | $62.32 | +$2,492,800 | 102,397 | Direct | |
| Jan 30, 2025 | Class A Common Stock | SSaleDisposed | −15,000 | $83.00 | −$1,245,000 | 87,397 | Direct | |
| Jan 30, 2025 | Class A Common Stock | SSaleDisposed | −25,000 | $86.00F2 | −$2,150,000 | 62,397 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Class A Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 16,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple transactions at prices ranging from $86.00 to $86.195, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.